secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001285550-23-000050
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro shareholders approve reduction of authorized shares from 200M to 90M
--------------------------------------------------------------------------------

- Authorized common stock reduced from 200M to 90M shares; 98.7% of votes cast in favor.
- All eight director nominees elected: Burnett, Fletcher, Fallon, Girin, Johnson, Klein, Liau, Richards.
- Cherry Bekaert LLP ratified as independent auditor for FY2023; advisory executive compensation approved.
- Broker non-votes of 4,856,372 occurred on director elections and executive compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000128555023000050/0001285550-23-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000128555023000050/clpt-20230525.htm
  HTML page:      https://secwatch.observer/filing/0001285550-23-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer